Pharmafile Logo
Pharmafocus logo
Advanced Search
Omontys image

Probe launched as deaths prompt Omontys recall

February 26, 2013
Manufacturing and Production Affymax, Takeda, omontys, recall

Reports of three fatal reactions linked to administration of Takeda and Affymax’ Omontys anaemia treatment have led to a recall …

News
elan image

Elan sceptical of Royalty

February 26, 2013
Sales and Marketing Elan, FDA, Tysabri, royalty pharma

Elan Corporation has poured tepid water on private equity firm Royalty Pharma’s putative offer this week for the Irish biotech …

News

Pharma manufacturing news in brief

February 26, 2013
Manufacturing and Production Baxter International, Bone Therapeutic, DSM Pharmaceutical Products and Chemtrix, Sovereign Pharmaceutical

Sovereign Pharma rapped by FDA, facility updates from Bone Therapeutics, Baxter and SHL, plus a continuous processing alliance between DSM …

News
GSK image

Abbott, GSK cut staff at Irish facilities

February 26, 2013
Manufacturing and Production Abbottt, GSK, Ireland

GlaxoSmithKline and Abbott have both announced job cuts at their facilities in Ireland in a blow to the country’s pharmaceutical …

News

Continuous processing production line set up in Finland

February 25, 2013
Manufacturing and Production Finland, PROMIS

A specialist centre in Finland providing expertise in the continuous processing of pharmaceuticals, first envisaged in 2008, opened its doors …

News
screen_shot_2013-02-25_at_16

Pharmalink Consulting appoints five consultants

February 25, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmalink Consulting

Regulatory affairs firm Pharmalink Consulting has announced the appointment and promotion of five consultants at their offices in the UK, …

Appointment
Abbott image

Abbott seeks leukemia test

February 25, 2013
Sales and Marketing AbbVie, Abbott, Janssen

Abbott is to team up with Janssen Biotech and biopharma firm Pharmacyclics to seek a diagnostic test for leukemia patients. …

News
herceptinbank

FDA approves Kadcyla

February 25, 2013
Herceptin, Roche, T-DM1

Roche’s new ‘smart bomb’ breast cancer drug Kadcyla has been approved by the FDA, giving it hope of replacing revenue …

News

$33m prizes for research

February 22, 2013
Research and Development Breakthrough Prize in Life Sciences, Cancer, Facebook, google

Life science research has a new multi-million dollar prize from the founders of Facebook and Google.The not-for-profit Breakthrough Prize in …

News

Ariad expands in Europe

February 22, 2013
Sales and Marketing Ariad, leukaemia, leukemia

The new European boss of Ariad Pharmaceuticals has sketched out the US firm’s plans for its next-generation leukaemia drug, which …

News
Roche image

Roche censured for drunken conference antics

February 21, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA, Roche

The conduct of senior Roche employees has come under the spotlight following a complaint about drunkenness and poor behaviour at …

News

Watson: the supercomputer revolution begins here

February 21, 2013
Medical Communications Watson, ibm

Watson, a supercomputer developed by IBM is to make its debut helping oncologists diagnose and choose the best treatment for …

News
LaMattina image

John LaMattina: Pharma’s reputation continues to suffer – what can be done to fix it?

February 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bad pharma, Goldacre, John LaMattina, industry, transparency

You don’t have too look far to find unflattering articles about the pharmaceutical industry. What was previously the domain of …

Feature

Pharma losing in ‘valley of death’

February 21, 2013
Research and Development, Sales and Marketing Bath, Evotec, pharma

An academic from Bath University has warned that much of pharma’s most promising research is being lost before it can …

News
hakan_bjorklund

Lundbeck elects new chairman

February 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck

Lundbeck has announced it will be electing Håkan Björklund as its new chairman as Mats Pettersson steps down. Pettersson, a …

Appointment

SHL to invest 40 Million USD in 2013 to significantly expand production facilities

February 21, 2013
Manufacturing and Production auto injectors, autoinjector, drug delivery, pen injectors

SHL announced plans this week to expand production facilities in Taiwan. A leader in the field of drug delivery devices …

News
Press release
johnny-marshall

NHS Confederation appoints two directors

February 20, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, confederation

The NHS Confederation has announced the appointment of two new directors to the organisation. Dr Johnny Marshall (pictured) and Matt …

Appointment
GSK image

FDA accepts GSK’s Anoro

February 20, 2013
Research and Development, Sales and Marketing FDA, GSK, Theravance, anoro

The FDA has accepted a New Drug Application for GlaxoSmithKline and biopharma firm Theravance’s investigational COPD drug UMEC/VI. A decision …

News

Phytopharm suffers Parkinson’s loss

February 20, 2013
Research and Development, Sales and Marketing Parkinson's, Phytopharm, cogane

Phytopharm is facing an uncertain future after the failure of one of its most promising drugs in a Phase II …

News

Strategic North launches thought leaders book

February 20, 2013
Medical Communications Strategic North, health policy

A healthcare consultancy has launched a book collecting thoughts and insights from experts in health and beyond.Strategic North, a strategic …

News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026